Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes
- 1 September 2018
- journal article
- research article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 105, 290-298
- https://doi.org/10.1016/j.biopha.2018.05.130
Abstract
No abstract availableFunding Information
- Deanship of Scientific Research, King Saud University
This publication has 57 references indexed in Scilit:
- Diabetes and renal tubular cell apoptosisWorld Journal of Diabetes, 2013
- Inflammation in Diabetic NephropathyMediators of Inflammation, 2012
- Induction of Oxidative Stress in KidneyInternational Journal of Nephrology, 2012
- Protective Effects of Simvastatin, a Lipid Lowering Agent, against Oxidative Damage in Experimental Diabetic RatsJournal of Lipids, 2011
- Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidasesKidney International, 2011
- Crosstalk of reactive oxygen species and NF-κB signalingCell Research, 2010
- The role of reactive oxygen species in apoptosis of the diabetic kidneyApoptosis, 2009
- Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetesFree Radical Biology & Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Diabetic Nephropathy: Mechanisms of Renal Disease ProgressionExperimental Biology and Medicine, 2008